Streptococcus pneumoniae articles & resources on Made-in-China.com

Additional Steps May Need to Be Taken to Protect Children and Adults

Jan 6, 2014

Germs that cause common illnesses, including ear infections and strep throat, can linger on surfaces such as cribs, children's toys and books for hours after contamination -- even after the objects are well cleaned -- according to a small ...

Tags: germs, Streptococcus pneumoniae, Streptococcus pyogenes, surface

The Findings Suggest Additional Precautions Might Be Necessary to Prevent Infections

Jan 3, 2014

Two bacteria that cause colds, ear infections, strep throat and more serious infections persist longer on dishes or toys than thought, U.S. researchers say. Senior author Anders Hakansson at the University at Buffalo's School of Medicine ...

Tags: Health, Medicine

GSK Has Received Positive Opinion From The EMA's

Oct 30, 2013

British drug maker GlaxoSmithKline (GSK) has received positive opinion from the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) for additional indication for Synflorix, a pediatric pneumococcal ...

Tags: drug, Pneumonia Indication

Pfizer Has Secured European Commission Approval to Carry out Updates

Oct 21, 2013

Pfizer has secured European Commission approval to carry out updates to the summary of product characteristics (SmPC) for its pneumococcal conjugate vaccine (PCV) Prevenar 13, regarding its use in certain high-risk populations. Now the ...

Tags: Pfizer, Label Update

Pfizer Has Obtained European Approval for The Expanded Use of Prevenar 13

Jul 12, 2013

Pfizer has obtained European approval for the expanded use of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), in adults between 18 to 49 years of age for the prevention of invasive pneumococcal disease. ...

Tags: Pneumococcal Vaccine, Medicine

TaiGen Biotechnology Has Submitted New Drug Application

May 22, 2013

TaiGen Biotechnology has submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug Administration (TFDA) and China Food and Drug Administration (CFDA). Nemonoxacin is the first ...

Tags: TaiGen Biotechnology, Medicine

FDA Approves for The Expanded Use of Prevnar 13, Pneumococcal Conjugate Vaccine

Jan 29, 2013

Pfizer has obtained FDA approval for the expanded use of Prevnar 13, pneumococcal conjugate vaccine, in children and adults between six to 17 years of age who are new to the vaccine. The single dose Pneumococcal 13-valent conjugate ...

Tags: FDA, vaccine, conjugate vaccine